期刊文献+

彩超在乳腺癌新辅助化疗中的应用价值 被引量:1

The efficacy of color doppler ultrasound in the evaluation of the neoadjuvant chemotherapy in patients with primary breast cancer
下载PDF
导出
摘要 目的通过对乳腺癌新辅助化疗前后超声各指标的变化进行观察分析,探讨彩超在乳腺癌新辅助化疗疗效评价中的应用价值。方法 106例乳腺癌患者110处乳腺癌病灶,均于新辅助化疗前后应用彩超对比分析肿瘤原发灶大小和形态,原发灶内血流分级及血流动力学变化及腋下淋巴结形态和血流变化。结果超声显示乳腺癌新辅助化疗后原发灶肿瘤体积显著缩小,形态变的不规则,边界多清晰可见,周边声带可消失,后方回声倾向正常。同时原发灶内血流减少甚至消失,血流动力学指数降低,淋巴结体积缩小,血流减少。结论新辅助化疗后,乳腺癌原发灶及淋巴结的彩超多项指标发生了显著的变化,因此彩超是评价乳腺癌新辅助化疗疗效的有效,无创,安全的检查方法 。 Objective To investigate the value of color doppler ultrasound changes of breast cancer in evaluation of therapeutic effect of neoadjuvant chemotherapy.Methods 106 patients with 110 breast cancers before and after neoadjuvant therapy were examined with color doppler ultrasound.The tumor position,size,configuration,the blood flow and hemodynamics index of the tumor,the axillary lymph nodes including the size,shape and internal blood were examined.Results After neoadjuvant chemotherapy,there was a significant decrease of tumor size,volume,morphology irregularity,existence of surrounding halo,distinct boundary,increasing of internal echoes,rear echo.At the same time,the blood flow and hemodynamics index of the tumor,the size,shape and internal blood of the axillary lymph nodes were also reduced.Conclusion The features of color doppler ultrasound changed significantly after neoadjuvant chemotherapy.Color doppler ultrasound provides a safe,effective and noninvasive method for observing the curative effect of neoadjuvant chemotherapy.
作者 邹力君
出处 《中国现代药物应用》 2011年第8期12-14,共3页 Chinese Journal of Modern Drug Application
关键词 乳腺癌 彩色多普勒超声 新辅助化疗 Breast cancer Color doppler ultrasound Neoadjuvant chemotherapy
  • 相关文献

参考文献8

二级参考文献76

共引文献72

同被引文献10

  • 1Bonadonna G,Valagussa P,Brambilla C,et al.Primary chemotherapy in operable breast cancer.Eight-year experience at the Milan cancer institute[J].Clin Oncol,1998 ;16 (1):93-100.
  • 2Ogston KN,Miller ID,Payne S,et al.A new histological grading system to assess response of breast cancer to primary chemotherapy:prognostic significance and survival [J].Breast,2003 ; 12(5):320-7.
  • 3Garces CA,Cance WG.Neoadjuvant chemotherapy of breast cancer[J].Am Surg,2004;70(7):565-9.
  • 4Wolmark N,Wang J,Mamounas E,et al.Preoperative chemotherapy in patients with operable breast cancer:nine-year results from National Surgical Adjuvant Breast and Bowel Project B-18[J].J Natl Cancer Inst Monogr,2001 ;30:96-102.
  • 5Chagpar AB,Middleton LP,Sahin AA,et al.Accuracy of physical examination,ultrasonography,and mammorgraphy in predicting residual pathologic tumor size in patients treated with neoadjuvant chemotherapy [J].Ann Surg,2006 ;243(2):257-64.
  • 6Workflow M C.The Workflow Reference Model[EB/OL].http://www.wfmc.org,2003.
  • 7孙冰,宋三泰,吴世凯,江泽飞,王涛,张少华,赵一冰,尉承泽,李晓兵,杨涛,李功杰.乳腺癌新辅助化疗疗效评价方法的比较[J].中华肿瘤杂志,2009,31(10):783-785. 被引量:18
  • 8陈丽荣.乳腺癌新辅助化疗的临床意义和病理学评价[J].中华病理学杂志,2010,39(4):218-221. 被引量:17
  • 9胡聂,梁庆模.乳腺癌新辅助化疗疗效评价方法研究进展[J].中国医药导报,2010,7(26):7-9. 被引量:4
  • 10孙强,周易冬,黄汉源,肖毅,茅枫.新辅助治疗在局部晚期乳腺癌中的应用[J].中国肿瘤临床,2003,30(4):283-285. 被引量:13

引证文献1

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部